Equity Analysis /
United States of America

US : Biotechnology - Biotechnology | First COVID Pill Likely to Receive Tepid Emergency Use Authorization Soon

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    1 December 2021
    Published by